Cargando…

Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study

[Image: see text] The current research reports the synthesis of 14 para-substituted thiosemicarbazone derivatives in good to excellent yields using standard procedures. Initially, 4-ethoxybenzaldehyde (1) and 4-nitrobenzaldehyde (2) were refluxed with thiosemicarbazide in the presence of acetic acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Momin, Gohar, Hina, Alam, Aftab, Wadood, Abdul, Shareef, Azam, Ali, Mahboob, Khalid, Asaad, Abdalla, Ashraf N., Ullah, Farhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910069/
https://www.ncbi.nlm.nih.gov/pubmed/36777613
http://dx.doi.org/10.1021/acsomega.2c08108
_version_ 1784884710179078144
author Khan, Momin
Gohar, Hina
Alam, Aftab
Wadood, Abdul
Shareef, Azam
Ali, Mahboob
Khalid, Asaad
Abdalla, Ashraf N.
Ullah, Farhat
author_facet Khan, Momin
Gohar, Hina
Alam, Aftab
Wadood, Abdul
Shareef, Azam
Ali, Mahboob
Khalid, Asaad
Abdalla, Ashraf N.
Ullah, Farhat
author_sort Khan, Momin
collection PubMed
description [Image: see text] The current research reports the synthesis of 14 para-substituted thiosemicarbazone derivatives in good to excellent yields using standard procedures. Initially, 4-ethoxybenzaldehyde (1) and 4-nitrobenzaldehyde (2) were refluxed with thiosemicarbazide in the presence of acetic acid in ethanol for 4–5 h. Then, various substituted phenacyl bromides were treated with the desired thiosemicarbazones (3 and 4) in the presence of triethylamine in ethanol with constant stirring for 5–6 h. The resulting derivatives were confirmed through electron impact mass spectrometry and (1)H NMR spectroscopy and evaluated for anticholinesterase inhibitory activity. Among the series, four compounds, 19, 17, 7, and 6, showed potent inhibitory activity against the acetylcholinesterase (AChE) enzyme, having IC(50) values of 110.19 ± 2.32, 114.57 ± 0.15, 140.52 ± 0.11, and 160.04 ± 0.02 μM, respectively, compared with standard galantamine (IC(50) = 104.5 ± 1.20 μM). Similarly, compounds 19 (IC(50) = 145.11 ± 1.03 μM), 9 (IC(50) = 147.20 ± 0.09 μM), 17 (IC(50) = 150.36 ± 0.18 μM), and 6 (IC(50) = 190.21 ± 0.13 μM) were the most excellent inhibitors of butyrylcholinesterase (BChE) when compared with the standard drug galantamine (IC(50) = 156.8 ± 1.50 μM). In silico studies were accomplished on the produced derivatives in order to explain the binding interface of compounds with the active sites of AChE and BChE enzymes.
format Online
Article
Text
id pubmed-9910069
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99100692023-02-10 Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study Khan, Momin Gohar, Hina Alam, Aftab Wadood, Abdul Shareef, Azam Ali, Mahboob Khalid, Asaad Abdalla, Ashraf N. Ullah, Farhat ACS Omega [Image: see text] The current research reports the synthesis of 14 para-substituted thiosemicarbazone derivatives in good to excellent yields using standard procedures. Initially, 4-ethoxybenzaldehyde (1) and 4-nitrobenzaldehyde (2) were refluxed with thiosemicarbazide in the presence of acetic acid in ethanol for 4–5 h. Then, various substituted phenacyl bromides were treated with the desired thiosemicarbazones (3 and 4) in the presence of triethylamine in ethanol with constant stirring for 5–6 h. The resulting derivatives were confirmed through electron impact mass spectrometry and (1)H NMR spectroscopy and evaluated for anticholinesterase inhibitory activity. Among the series, four compounds, 19, 17, 7, and 6, showed potent inhibitory activity against the acetylcholinesterase (AChE) enzyme, having IC(50) values of 110.19 ± 2.32, 114.57 ± 0.15, 140.52 ± 0.11, and 160.04 ± 0.02 μM, respectively, compared with standard galantamine (IC(50) = 104.5 ± 1.20 μM). Similarly, compounds 19 (IC(50) = 145.11 ± 1.03 μM), 9 (IC(50) = 147.20 ± 0.09 μM), 17 (IC(50) = 150.36 ± 0.18 μM), and 6 (IC(50) = 190.21 ± 0.13 μM) were the most excellent inhibitors of butyrylcholinesterase (BChE) when compared with the standard drug galantamine (IC(50) = 156.8 ± 1.50 μM). In silico studies were accomplished on the produced derivatives in order to explain the binding interface of compounds with the active sites of AChE and BChE enzymes. American Chemical Society 2023-01-25 /pmc/articles/PMC9910069/ /pubmed/36777613 http://dx.doi.org/10.1021/acsomega.2c08108 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Khan, Momin
Gohar, Hina
Alam, Aftab
Wadood, Abdul
Shareef, Azam
Ali, Mahboob
Khalid, Asaad
Abdalla, Ashraf N.
Ullah, Farhat
Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
title Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
title_full Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
title_fullStr Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
title_full_unstemmed Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
title_short Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
title_sort para-substituted thiosemicarbazones as cholinesterase inhibitors: synthesis, in vitro biological evaluation, and in silico study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910069/
https://www.ncbi.nlm.nih.gov/pubmed/36777613
http://dx.doi.org/10.1021/acsomega.2c08108
work_keys_str_mv AT khanmomin parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT goharhina parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT alamaftab parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT wadoodabdul parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT shareefazam parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT alimahboob parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT khalidasaad parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT abdallaashrafn parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy
AT ullahfarhat parasubstitutedthiosemicarbazonesascholinesteraseinhibitorssynthesisinvitrobiologicalevaluationandinsilicostudy